Lung cancer study aims to match patients to precision treatments

NCT ID NCT02688894

First seen May 04, 2026 · Last updated May 06, 2026 · Updated 2 times

Summary

This study screens up to 797 people with relapsed small cell lung cancer to identify genetic changes in their tumors. Researchers use tissue and blood samples to look for specific markers that could make them eligible for future targeted therapy trials. No experimental drugs are given in this study—it is purely for gathering information to guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chungbuk University Hospital

    COMPLETED

    Jungbuk, South Korea

  • Gachon University Gil Medical Center

    COMPLETED

    Incheon, South Korea

  • Samsung Medical Center

    RECRUITING

    Seoul, 135-710, South Korea

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Seoul National University Bundang Hospital

    COMPLETED

    Seongnam, South Korea

  • Ulsan University Hospital

    COMPLETED

    Ulsan, South Korea

  • VHS Medical Center

    COMPLETED

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.